Olebiome® (Made in France) Formulas mimic Intracellular vesicles- lipid droplets-LD: essential organelles for cellular energy and metabolism network. Intraxome LD- mimic LD through Biomimetic Intelligence- BI engineering.
Exosomes/ EV-
Extracellular Vesicles- of
validated market trend➔
educated users.
• Olive oil: a natural lipid droplet, enriched with
Triolein, similar to human sebum (LD) .
• Olebiome developing methods to generate TriAza.
Formula of based on MoCL esters -target
microbiome balance
• Formula designed for sensitive skin, support skin
barrier during menopause period, and aesthetic
procedures, minimalistic and multitasking
Deep science innovation of
traditional longevity oils
• 1994-Master studies-in lipid-based host-pathogen interaction (HUJI)
• 1998- Ph.D. and Postdoc (WIS)- oxidative stress and lipid bio
protection in (Neurochemistry and Membrane research). M.B.A. -
Melbourne, Australia, Neuroscience Fellow- Amherst Boston. Fellow Paul
Merage Irvine Business School, OC, USA. Author of 40+ patents and
publications.
• 2000- CEO Vecta Pharmaceuticals Ltd.- GMP of peptide therapy,
clinical trials Phase 2a- in Sheba hospital and licensing deal with UCLA,
multimillion grants.
• 2005- VP business development , Protalix Inc. (NASDAQ), multiple
deals (merge deal-bill. USD).
• 2008- CEO of Bioind (acquired by Sartorius Group)- led GMP, export –
built marketing in USA, East Europe and China, and import (40 countries)
and led R&D Nutristem- MSC, iPSC cell culture brand for clinical GMP use.
Member of Israel- Germany Trade org.
• 2012: Founded multiple start ups in Israel (Acceleta Ltd.-Technion
Haifa), Brazil (Cellavita Ltd.-Sao Paolo University), Australia- Melbourne
(Cellelska Pty. Ltd.-TGA approval for phase 1-2), GMP- cell therapy, clinical
formulations. Strategic consultant in ATCC- introduced tissue organoids
deal and exosome standards. Strategic global consultant for academia
and public companies.
• 2019-2021: Executed IP deal for exosomes, Bioxomes- EV mimetics
with NASDAQ company (multimillions Wallonia-Belgium- and European
grants);
• 2021-2025 : Founded Olebiome® brand- clinical development in
Europe, scale up for commercial production in France, distribution unit
Olebiome USA LLC in Florida. AASCP- GMP lectures and certifications:
2024-2025.
Sabina Glozman
25+ yrs. in lipids, formulations and cell biology and global management
